The management board of AGILeBiotics attended the BioPharm America meeting on 25-27th September 2017. It was a great opportunity to network with investors and CROs, which are in the business of drug development.
Menu
News
About
AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections
